United Guardian (UG) EBITDA Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
United Guardian (UG) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | -341.00 |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | -24.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.00 |
| Mar 31, 2026 | -226.00 |
| Dec 31, 2025 | 191.00 |
| Sep 30, 2025 | -2,152.00 |
| Jun 30, 2025 | -838.00 |
| Mar 31, 2025 | -692.00 |
| Dec 31, 2024 | -789.00 |
| Sep 30, 2024 | 741.00 |
| Jun 30, 2024 | 1,333.00 |
| Mar 31, 2024 | -82.00 |
| Dec 31, 2023 | 698.00 |
| Sep 30, 2023 | -484.00 |
| Jun 30, 2023 | -1,354.00 |
| Mar 31, 2023 | -627.00 |
| Dec 31, 2022 | -1,370.00 |
| Sep 30, 2022 | -1,148.00 |
| Jun 30, 2022 | -834.00 |
| Mar 31, 2022 | -580.00 |
| Dec 31, 2021 | 1,565.00 |
| Sep 30, 2021 | 768.00 |